Skip to content
Screener

CareDx CDNA Q3 2026 earnings

Reported October 29, 2026 · After market close

Revenue$139.4MBeat by $17.4M
EPS$0.70Beat by $0.45
Revenue estimate$122.0M
EPS estimate$0.25
“We delivered another strong quarter of solid execution, with continued growth in Transplant, progress scaling Specialty Oncology, and important advances across our pipeline and clinical evidence, including in Cell Therapy. We see significant clinical interest in how molecular information can inform more decisions across a patient's care journey, while continuing to make our solutions easier for providers to adopt and patients to access. We believe these dynamics create meaningful opportunities for continued profitable growth.”
John Hanna

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$139.4M+39.3%
Operating income$8.1M+3,398%
Net income$19.3M+1,052%
EPS (diluted)$0.35+1,067%

Balance sheet

See full
Cash & equivalents$250.5M+172%
Total debt$29.0M+4.9%
Total equity$467.5M+50.2%
Total assets$641.5M+48.4%

Cash flow

See full
Operating cash flow$12.7M-66.0%
CapEx$1.6M—
Free cash flow$11.1M—

Valuation & ratios

Valuation

as of 10/30/26
See full
Market cap$3.7B+380%
Enterprise value$3.48B+393%
P/E28.8×+17.8×
P/S7.4×+5.3×

Profitability

See full
Operating margin23.4%+6.8pp
Net margin25.9%+6.2pp

Returns & leverage

See full
Return on equity33%+8.9pp
Debt / equity0.1×0.0×
Current ratio2.3×-0.7×

Segments

By product

See full
Testing services revenue$119.2M+65.2%
Patient and digital solutions revenue$20.2M+30.9%

By segment

See full
Reportable Segment$139.4M+39.3%

FAQ

When did CareDx report Q3 2026 earnings?
CareDx (CDNA) reported Q3 2026 earnings on October 29, 2026 after market close.
What were CareDx's Q3 2026 revenue and EPS?
CareDx reported revenue of $139.4M and eps of $0.70 for Q3 2026.
Did CareDx beat estimates in Q3 2026?
Revenue beat the consensus estimate of $122.0M by $17.4M. EPS beat the consensus estimate of $0.25 by $0.45.
How did CareDx's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 39.3% from $100.1M a year earlier and eps grew 150.0% from $0.28.
Where can I find CareDx's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001217234-26-000059) and the 10-Q periodic report (0001217234-26-000061) directly on SEC EDGAR. The filing index links above go to sec.gov.